Subversion of pulmonary dendritic cell function by paramyxovirus infections

Keyphrases

• Acute Phase 16%
• Age of Infection 16%
• Airway Morbidity 16%
• Antiviral Immunity 16%
• Carbon Tetrachloride 33%
• CCL3 33%
• CCL5 16%
• CD4+ T Cells 16%
• Chemokine (C-C motif) Ligand 2 (CCL2) 16%
• Conventional DCs 33%
• Dendritic Cell Function 100%
• Dendritic Cell Subsets 16%
• Dendritic Cell Trafficking 16%
• Dendritic Cells 16%
• Differential Recruitment 16%
• Experimental Infection 16%
• Human Metapneumovirus (hMPV) 100%
• Human Respiratory Tract 83%
• Immune Function 16%
• In Vitro Infection 16%
• Infected Mice 16%
• Interleukin-6 16%
• Killer Dendritic Cells 16%
• Lower Respiratory Tract Infection 16%
• Lung 83%
• Lung Dendritic Cells 33%
• Paramyxovirus 100%
• Plasmacytoid DC 50%
• Plasmacytoid Dendritic Cells 16%
• Pulmonary Dendritic Cells 100%
• Respiratory Syncytial Virus 66%
• Respiratory Syncytial Virus Infection 33%
• Subversion 100%
• Toll-like Receptor 9 (TLR9) 16%
• Tumor-draining Lymph Nodes 16%
• Virus 16%

Immunology and Microbiology

• Adaptive Immune System 16%
• CCL2 16%
• CCL3 33%
• CCL5 16%
• Cell Migration 16%
• Cytokine 33%
• Dendritic Cell 83%
• Dendritic Cell Function 100%
• Dendritic Cell Subset 16%
• Human Metapneumovirus 100%
• Human Respiratory Syncytial Virus 66%
• Immunity 16%
• Interleukin 6 16%
• Lower Respiratory Tract 16%
• Lymph Node 16%
• Paramyxoviridae 100%
• Plasmacytoid Dendritic Cell 16%
• Respiratory Syncytial Virus Infection 33%
• T-Helper Cell 16%
• TLR9 16%
• Tumor Necrosis Factor 33%